Trial · NCT02633878
Chinese Herbal Medicine (New "Shoutai Wan") and/or Oral Progesterone Intervention Trial for Threatened Miscarriage
NCT02633878, Phase 3, Completed, Heilongjiang University of Chinese Medicine
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Chinese Herbal Medicine (New "Shoutai Wan") and/or Oral Progesterone Intervention Trial for Threatened Miscarriage. Trials, record NCT02633878. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02633878
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Chinese Herbal Medicine (New "Shoutai Wan") and/or Oral Progesterone Intervention Trial for Threatened Miscarriage
- NCT number
- NCT02633878
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 1,656 participants, actual
- Lead sponsor
- Heilongjiang University of Chinese Medicine
- Conditions
- Threatened Miscarriage
- Interventions
Chinese Herbal Medicine (New "Shoutai Wan") plus Oral Progesterone, Chinese Herbal Medicine (New "Shoutai Wan") plus Oral Progesterone Placebo, Chinese Herbal Medicine Placebo (New "Shoutai Wan" placebo) plus Oral Progesterone, Chinese Herbal Medicine Placebo (New "Shoutai Wan" placebo) plus Oral Progesterone Placebo
- First posted
- 2015-12-17
- Last updated
- 2026-01-13
Source ClinicalTrials.gov
Registered outcomes48
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Live birth | At or beyond 20 completed weeks' gestation | Rate of live birth at or beyond 20 completed weeks' gestation |
| Secondary | Pregnancy outcome: Ongoing pregnancy | Beyond 12 weeks' gestation | Rate of ongoing pregnancy (beyond 12 weeks' gestation) |
| Secondary | Pregnancy outcome: Miscarriage during the first trimester | During the first trimester (at or before 12 weeks' gestation) | Rate of miscarriage during the first trimester (at or before 12 weeks' gestation) |
| Secondary | Pregnancy outcome: Miscarriage during second and third trimesters | During second and third trimesters (beyond 12 weeks' gestation until 20 weeks) | Rate of miscarriage during second and third trimesters (beyond 12 weeks' gestation until 20 weeks) |
| Secondary | Pregnancy outcome: Termination | At any time during treatment (up to 2 months) and follow-up period (up to 1 year) | Rate of termination at any time during treatment and follow-up period |
| Secondary | Pregnancy outcome: Stillbirth | At or beyond 20 weeks' gestation | Rate of stillbirth (at or beyond 20 weeks' gestation) |
| Secondary | Pregnancy outcome: Induced abortion | At any time during treatment (up to 2 months) and follow-up period (up to 1 year) | Rate of induced abortion at any time during treatment and follow-up for any reasons |
| Secondary | Pregnancy outcome: Gestational age at delivery | Up to 1 day after delivery | Gestational age at delivery (weeks and days) |
| Secondary | Pregnancy outcome: Preterm birth | Birth before 37 completed weeks' gestation (up to and including 36 weeks and 6 days of gestation) | Rate of preterm birth (birth beyond 28 week and before 37 completed weeks' gestation (up to and including 36 weeks and 6 days of gestation)) |
| Secondary | Pregnancy outcome: Extreme preterm birth | Birth beyond 20 weeks and before 28 completed weeks' gestation (up to and including 27 weeks and 6 days of gestation) | Rate of extreme preterm birth (birth beyond 20 weeks and before 28 completed weeks' gestation (up to and including 27 weeks and 6 days of gestation)) |
1 to 10 of 48Source ClinicalTrials.gov
See all 48 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02633878
GET https://conductscience.org/api/trials/v1/NCT02633878/registered?page=2